“Lifestyle interventions promoting weight loss and physical activity are recommended for overweight and obese people with Type 2 diabetes to improve their health,” said Mark A. Espeland, Ph.D., professor of public health sciences at Wake Forest Baptist Medical Center and lead author of the study. “This is the first study to show that weight loss can also save money for these individuals by reducing their health care needs and costs.”
The research is published in the Aug. 21 online issue of the journal Diabetes Care.
The study evaluated 5,121 obese and overweight people between the ages of 45 and 76 with Type 2 diabetes who participated in the National Institute of Health-sponsored Action for Health in Diabetes (Look AHEAD) study beginning in 2001. Half of the participants at each of the study’s 16 sites across the country were randomly assigned to intensive lifestyle intervention (ILI) or diabetes support and education (DSE) programs, and their medical histories were tracked through 2012.
Those in the ILI group had 11 percent fewer hospitalizations and 15 percent shorter hospital stays. They also used fewer prescription New Linkmedications. Both of these benefits of ILI contributed to an average saving of $5,280 per person in health care costs over 10 years (or $528 per year).
Espeland said the people in the ILI program maintained lower weights and higher levels of physical activity throughout the study than those in the DSE group, resulting in better control of their diabetes, blood pressure, sleep quality, physical function and symptoms of depression. He added that the cost savings for those in the ILI group were relatively consistent regardless of age, initial weight, gender or ethnicity.
“Type 2 diabetes is a chronic disease that is affecting more and more adults, increasing their health care needs and costs,” Espeland said. “This study shows that by losing weight and being physically active, individuals can reduce these costs.”
The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health with additional support from the National Heart, Blood and Lung Institute of the NIH and the Centers for Disease Control and Prevention.
Co-authors of the study are Alain Bertoni, M.D., Julia Rushing, M.S., and Don G. Hire, B.S., Wake Forest Baptist; Henry A. Glick, Ph.D., and Thomas A. Wadden, Ph.D., University of Pennsylvania; Frederick L. Brancati, M.D., and Jeanne M. Clark, M.D., Johns Hopkins School of Medicine; George A. Bray, M.D., and Donna H. Ryan, M.D., Pennington Biomedical Research Center; Jeffrey M. Curtis, M.D., William C. Knowler, M.D., Ph.D., and Tina Killean, Phoenix Indian Medical Center; Rena R. Wing, Ph.D., and Caitlin Egan, M.S., Brown Medical School/The Miriam Hospital; Mary Evans, Ph.D., Van S. Hubbard, M.D., Ph.D., and Susan Z. Yanovski, M.D., National Institute of Diabetes and Digestive and Kidney Diseases; John P. Foreyt, Ph.D., and Henry Pownall, Ph.D., Baylor College of Medicine; Siran Ghazarian, M.D., and Anne L. Peters, M.D., Roybal Comprehensive Health Center; Edward W. Gregg, Ph.D., and Ping Zhang, Ph.D., Centers for Disease Control and Prevention; Helen P. Hazuda, Ph.D., and Maria G. Montez, M.S., University of Texas Health Sciences Center at San Antonio; James O. Hill, Ph.D., Adam G. Tsai, M.D., and Marsha Miller, University of Colorado Health Sciences Center at Aurora; Edward S. Horton, M.D., Joslin Diabetes Center; John M. Jakicic, Ph.D., and Andrea Kriska, Ph.D., University of Pittsburgh; Robert W. Jeffery, Ph.D., and J. Bruce Redmon, M.D., University of Minnesota; Karen C. Johnson, M.D., Abbas E. Kitabchi, M.D., and Ebenezer A. Nyenwe, M.D., University of Tennessee Health Sciences Center at Memphis; Steven E. Kahn, M.B., and Anne Murillo, B.S., University of Washington; Cora E. Lewis, M.D., and Monika Safford, M.D., University of Alabama at Birmingham; David M. Nathan, M.D., Massachusetts General Hospital; and Xavier P. Sunyer, M.D., and Jennifer Patricio, M.S., St. Luke’s-Roosevelt Hospital.